Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Laboratory Corp. of America Holdings    LH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Laboratory Corp. of America Holdings : LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/13/2012 | 10:05pm CEST

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that for the period of March 12, 2012 to September 11, 2012, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended March 7, 2012, in addition to the continued accrual of the original issue discount. Contingent cash interest, which the Company has determined to be approximately $1.50 per Note, will be payable to holders of the Zero Coupon Notes as of the record date, which is August 26, 2012. The payment of contingent cash interest is expected to be made on September 11, 2012.

About LabCorp®

Laboratory Corporation of America® Holdings, an S&P 500 company, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $5.5 billion in 2011, over 31,000 employees worldwide, and more than 220,000 clients, LabCorp offers more than 4,000 tests ranging from routine blood analyses to reproductive genetics to companion diagnostics. LabCorp furthers its scientific expertise and innovative clinical testing technology through its specialized labs and the LabCorp Specialty Testing Group: The Center for Molecular Biology and Pathology, National Genetics Institute, ViroMed Laboratories, Inc., The Center for Esoteric Testing, Litholink Corporation, Integrated Genetics, Integrated Oncology, DIANON Systems, Inc., Monogram Biosciences, Inc., Colorado Coagulation, and Endocrine Sciences. LabCorp conducts clinical trials testing through its Esoterix Clinical Trials Services. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about our organization, visit our Web site at: www.labcorp.com.

This press release contains forward-looking statements. Each of the forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace and adverse actions of governmental and other third-party payors. Actual results could differ materially from those suggested by these forward-looking statements. Further information on potential factors that could affect LabCorp's financial results is included in the Company's Form 10-K for the year ended December 31, 2011, and subsequent SEC filings.

LabCorp
Stephen Anderson, 336-436-5274
www.labcorp.com


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LABORATORY CORP. OF AMERIC
04/21 LABORATORY OF AMERICA : Covance to Expand Large-Molecule Development Capabilitie..
04/12 LABORATORY OF AMERICA : Class-action suit alleges LabCorp overcharging customers
04/06 WOLF POPPER LLP : Quest Diagnostics And LabCorp Sued For Excessive Charges
04/04 LABORATORY CORP OF AMERICA HOLDINGS : Regulation FD Disclosure (form 8-K)
04/03 LABORATORY OF AMERICA : Conversion Right Triggered for LabCorp’s Zero Coup..
03/30 LABORATORY CORP OF AMERICA HOLDINGS : Regulation FD Disclosure (form 8-K)
03/30 LABORATORY OF AMERICA : LabCorp Commends Reps. Dr. Bucshon, DeGette for Releasin..
03/29 LABORATORY CORP OF AMERICA HOLDINGS : Other Events, Financial Statements and Exh..
03/29 LABORATORY OF AMERICA : LabCorp Promotes Executive Gary Huff to CEO of LabCorp D..
03/13 INSIDER TRADING ACTIVITY LABORATORY : LH) – CFO Sold 2,300 shares of Stoc..
More news
Sector news : Healthcare Facilities & Services - NEC
12:32a Fresenius snaps up Akorn, Merck KGaA's biosimilars in separate deals
04/24DJFresenius Kabi To Strengthen And Diversify Product Portfolio By Acquiring Ako..
04/17DJPLEASE DISREGARD HCA REVENUE, NET IN : 30 a.m. ET
04/12 FTSE slips from three-week highs as Tesco slumps
04/12 Denmark's Novo A/S ups Synlab stake to 20 percent before possible IPO
More sector news : Healthcare Facilities & Services - NEC
News from SeekingAlpha
04/24 Notable earnings before Tuesday?s open
03/29 INC RESEARCH : A Top-Tier CRO At A Low-Tier Price
03/15 PRA Health Sciences' Special Mix Could Have More To Offer
03/08 OPKO : Don't Count It Out
03/07 Laboratory Corporation of America (LH) Presents At The Raymond James 38th Ann..
Advertisement
Financials ($)
Sales 2017 9 935 M
EBIT 2017 1 663 M
Net income 2017 872 M
Debt 2017 4 783 M
Yield 2017 -
P/E ratio 2017 16,89
P/E ratio 2018 15,82
EV / Sales 2017 1,96x
EV / Sales 2018 1,80x
Capitalization 14 677 M
More Financials
Chart LABORATORY CORP. OF AMERIC
Duration : Period :
Laboratory Corp. of Americ Technical Analysis Chart | LH | US50540R4092 | 4-Traders
Full-screen chart
Technical analysis trends LABORATORY CORP. ...
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 157 $
Spread / Average Target 9,3%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David P. King Chairman, President & Chief Executive Officer
Glenn A. Eisenberg Chief Financial Officer, Treasurer & Executive VP
Mark Elliott Brecher Chief Medical Officer & Senior Vice President
Lance V. Berberian Chief Information Officer & Senior Vice President
Marcia T. Eisenberg Chief Scientific Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LABORATORY CORP. OF AM..11.61%14 677
HCA HOLDINGS INC12.87%30 950
FRESENIUS MEDICAL CARE..-0.80%26 307
QUEST DIAGNOSTICS INC12.40%14 167
DAVITA INC5.51%13 182
UNIVERSAL HEALTH SERVI..11.71%11 409
More Results